International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Propylthiouracil 5 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2020 - Volume 24, Number 2
View All Articles in Issue

Page(s): 135

Propylthiouracil 5 mg/mL in SyrSpend SF pH4 Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Propylthiouracil 5 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, propylthiouracil, formulation, stability, storage temperature, antithyroid agent, thryoid disorders, hyperthyroidism, thiocarbamide compound

Related Categories: EXCIPIENTS, FORMULATIONS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Propylthiouracil 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 135
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4 de Oliveira Ferreira Anderson, Polonini Hudson, Loures da Silva Sharlene, Buzinari Aglio Natália Cristina, Abreu Jordana, Fernandes Brandão Marcos Antônio	Jul/Aug 2017 Pg. 339-346
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Propylthiouracil 5-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 67
Prednisolone 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2020 Pg. 229
Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 133
Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2020 Pg. 134
Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 136
Terbinafine 25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 137
Topiramate 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 138
Acetazolamide 25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 130
Haloperidol 0.5-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 417
Stability of an Extemporaneously Compounded Propylthiouracil Suspension Alexander Kenneth S, Mitra Pallabi	Jan/Feb 2005 Pg. 82-86
Basics of Compounding for Disorders of the External Ear Allen Loyd V Jr	Jan/Feb 2004 Pg. 46-48
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Allen Loyd V Jr	Nov/Dec 2019 Pg. 487
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF Geiger Christine M, Sorenson Bridget, Whaley Paul	Sep/Oct 2015 Pg. 420-427
Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations Newton David W	Jul/Aug 2019 Pg. 281-287
Return to Top